7Baggers
Quarterly
Annual
    Unit: USD2025-07-27 2025-04-27 2025-01-26 2024-10-27 2024-07-28 2024-04-28 2024-01-28 2023-10-29 2023-07-30 2023-04-30 2023-01-29 2022-10-30 2022-07-31 2022-05-01 2022-01-30 2021-10-31 2021-08-01 2021-05-02 2021-01-31 2020-11-01 2020-08-02 2020-05-03 2020-02-02 2019-04-28 2019-01-27 2018-07-29 2018-04-29 2018-01-28 2017-07-30 2017-04-30 2017-01-29 2016-04-30 2016-01-31 
      
                                     
      cash flows from operating activities
                                     
      net income
    1,271,000,000 1,800,000,000 867,000,000  1,730,000,000 2,368,000,000 1,748,000,000  2,972,000,000 2,858,000,000 1,957,000,000  1,885,000,000 2,097,000,000 904,000,000 402,000,000 1,668,000,000 1,790,000,000 1,224,000,000 192,000,000 811,000,000 666,000,000 518,000,000 1,136,300,000 499,600,000 911,300,000 1,209,600,000 -534,700,000 653,100,000 802,200,000 193,200,000 494,700,000 253,800,000 
      adjustments to reconcile net income to net cash from operating activities:
                                     
      benefit from credit losses
    84,000,000 105,000,000 69,000,000                     34,100,000 2,500,000 39,300,000 24,300,000 2,500,000 44,200,000 26,100,000 6,500,000 25,700,000 9,400,000 
      benefit from depreciation and amortization
    564,000,000 555,000,000 549,000,000  553,000,000 525,000,000 520,000,000  532,000,000 501,000,000 494,000,000             513,200,000 503,300,000 494,000,000 487,600,000 463,200,000 435,900,000 427,400,000 415,700,000 387,600,000 374,200,000 
      impairments and other adjustments
    61,000,000 -32,000,000                              
      share-based compensation expense
    50,000,000 26,000,000 28,000,000  55,000,000 58,000,000 46,000,000  58,000,000 31,000,000 23,000,000             24,100,000 20,300,000 23,000,000 23,100,000 16,700,000 18,400,000 14,100,000 18,200,000 14,500,000 17,500,000 
      credit for deferred income taxes
        -5,000,000                             
      changes in assets and liabilities:
                                     
      receivables related to sales
    575,000,000 -2,132,000,000 1,063,000,000  23,000,000 -2,192,000,000 -277,000,000  -652,000,000                         
      inventories
    246,000,000 23,000,000 -795,000,000  643,000,000 314,000,000 -723,000,000  319,000,000 297,000,000 -1,279,000,000             1,600,000 -1,395,900,000 258,000,000 -558,000,000 -1,238,800,000 -257,600,000 -347,300,000 -743,100,000 159,500,000 -565,300,000 
      accounts payable and accrued expenses
    181,000,000 947,000,000 -1,845,000,000  285,000,000 1,027,000,000 -2,327,000,000  360,000,000 1,264,000,000 -1,577,000,000             631,100,000 -697,500,000 -93,900,000 1,222,000,000 -915,100,000 212,600,000 821,300,000 -717,700,000 501,700,000 -869,500,000 
      accrued income taxes payable/receivable
    393,000,000 -540,000,000  60,000,000 -212,000,000 183,000,000  -499,000,000 -295,000,000 199,000,000             59,100,000 97,900,000 22,700,000 -272,100,000 425,100,000 -27,300,000 179,600,000 15,500,000 253,500,000 -241,500,000 
      retirement benefits
    -19,000,000 -106,000,000 -688,000,000  -38,000,000 -79,000,000 -129,000,000  -48,000,000 -20,000,000 -48,000,000             24,600,000 -4,300,000 -882,300,000 2,000,000 65,600,000 57,500,000 69,100,000 46,500,000 68,300,000 22,800,000 
      other
    -4,000,000 286,000,000 -16,000,000  -255,000,000 90,000,000 -7,000,000  28,000,000 -38,000,000 186,000,000             183,600,000 -106,300,000 26,500,000 -117,700,000 -19,500,000 -53,900,000 16,200,000 -44,100,000 20,200,000 -76,300,000 
      net cash from operating activities
    2,896,000,000 1,700,000,000 -1,132,000,000 -4,138,990,769 3,195,000,000 1,852,000,000 -908,000,000 -2,895,991,411 3,043,000,000 1,099,000,000 -1,246,000,000 -417,995,301            155,900,000 -1,650,700,000 547,000,000 75,100,000 -1,296,800,000 904,300,000 567,400,000 -742,400,000 465,200,000 -777,600,000 
      capex
    -297,000,000 -203,000,000 -352,000,000 -324,000,000 -357,000,000 -362,000,000 -303,000,000 -269,000,000 -315,000,000            -193,500,000 -297,400,000 -218,400,000 -175,900,000 -176,300,000 -120,700,000 -97,800,000 -155,200,000 -92,600,000 -140,000,000 
      free cash flows
    2,599,000,000 1,497,000,000 -1,484,000,000 -4,138,990,769 2,871,000,000 1,495,000,000 -1,270,000,000 -2,895,991,411 2,740,000,000 830,000,000 -1,561,000,000 -417,995,301            -37,600,000 -1,948,100,000 328,600,000 -100,800,000 -1,473,100,000 783,600,000 469,600,000 -897,600,000 372,600,000 -917,600,000 
      ​
                                     
      cash flows from investing activities
                                     
      collections of receivables
    5,364,000,000 6,211,000,000 8,137,000,000  5,440,000,000 5,951,000,000 7,752,000,000  4,999,000,000 5,395,000,000 7,198,000,000             3,678,900,000 5,496,400,000 3,381,000,000 3,554,800,000 5,226,100,000 3,106,400,000 3,413,200,000 4,814,800,000 3,487,200,000 4,633,400,000 
      proceeds from maturities and sales of marketable securities
    114,000,000 184,000,000 61,000,000  133,000,000                   22,400,000 7,900,000 32,000,000 10,700,000 13,100,000 347,500,000 17,600,000 23,700,000 52,700,000 18,700,000 
      proceeds from sales of equipment on operating leases
    407,000,000 568,000,000 433,000,000  440,000,000 505,000,000 506,000,000  452,000,000 496,000,000 497,000,000             452,600,000 370,800,000 367,000,000 409,000,000 339,600,000 300,200,000 418,200,000 368,200,000 339,300,000 290,800,000 
      cost of receivables acquired
    -6,218,000,000 -6,699,000,000 -6,045,000,000  -7,022,000,000 -7,644,000,000 -6,447,000,000  -7,263,000,000 -7,129,000,000 -6,322,000,000             -4,673,900,000 -4,212,800,000 -4,404,400,000 -4,174,600,000 -4,006,600,000 -3,697,000,000 -3,984,000,000 -3,644,600,000 -3,556,300,000 -3,316,600,000 
      acquisitions of businesses, net of cash acquired
            -41,000,000                 200,000 -41,400,000 -5,129,700,000      
      purchases of marketable securities
    -251,000,000 -206,000,000 -141,000,000  -140,000,000                   -28,100,000 -31,500,000 -38,600,000 -38,500,000 -24,300,000 -33,300,000 -22,000,000 -21,700,000 -40,500,000 -71,700,000 
      purchases of property and equipment
    -297,000,000 -203,000,000 -352,000,000  -324,000,000 -357,000,000 -362,000,000  -303,000,000 -269,000,000 -315,000,000             -193,500,000 -297,400,000 -218,400,000 -175,900,000 -176,300,000 -120,700,000 -97,800,000 -155,200,000 -92,600,000 -140,000,000 
      cost of equipment on operating leases acquired
    -755,000,000 -815,000,000 -439,000,000  -796,000,000 -915,000,000 -454,000,000  -739,000,000 -732,000,000 -497,000,000             -562,700,000 -361,400,000 -501,200,000 -560,800,000 -365,700,000 -470,200,000 -542,500,000 -382,600,000 -633,700,000 -570,400,000 
      collections of receivables from unconsolidated affiliates
    100,000,000                                 
      collateral on derivatives – net
    100,000,000 218,000,000 -191,000,000  294,000,000 -214,000,000 310,000,000                           
      net cash from investing activities
    -1,580,000,000 -637,000,000 1,416,000,000 3,670,993,536 -2,001,000,000 -2,887,000,000 1,217,000,000 4,562,991,251 -3,069,000,000 -2,254,000,000 760,000,000 4,429,991,515            -1,340,800,000 968,600,000 -1,312,000,000 -1,062,700,000 -4,090,300,000 -601,700,000 -803,900,000 1,104,400,000 -641,600,000 851,600,000 
      cash flows from financing activities
                                     
      net payments in short-term borrowings
      -1,484,000,000                               
      proceeds from borrowings issued
    5,551,000,000 1,988,000,000 3,168,000,000  5,323,000,000 4,902,000,000 5,287,000,000                           
      payments of borrowings
    -2,906,000,000 -3,084,000,000 -1,753,000,000  -2,653,000,000 -4,902,000,000 -3,237,000,000                           
      repurchases of common stock
    -298,000,000 -397,000,000 -441,000,000  -805,000,000 -1,094,000,000 -1,328,000,000  -2,117,000,000 -1,289,000,000 -1,257,000,000             -336,500,000 -143,900,000 -393,400,000 -50,900,000 -9,700,000 -6,200,000 -97,600,000 -107,800,000 
      dividends paid
    -439,000,000 -440,000,000 -403,000,000  -406,000,000 -410,000,000 -386,000,000  -368,000,000 -356,000,000 -341,000,000             -242,000,000 -220,300,000 -195,700,000 -193,900,000 -193,000,000 -191,800,000 -190,600,000 -188,900,000 -190,100,000 -193,100,000 
      net cash from financing activities
    -736,000,000 102,000,000 -923,000,000 788,997,283 373,000,000 1,483,000,000 -2,645,000,000 -3,378,997,192 1,362,000,000 2,356,000,000 -339,000,000 -514,999,174            1,069,400,000 402,800,000 560,700,000 1,326,300,000 -231,000,000 1,584,000,000 840,500,000 -768,500,000 763,800,000 -742,900,000 
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    88,000,000 107,000,000 -87,000,000 5,999,963 -1,000,000 -21,000,000 16,000,000 -124,999,969 55,000,000 8,000,000 62,000,000 142,999,776            -21,900,000 -12,900,000         
      net increase in cash, cash equivalents, and restricted cash
    668,000,000   327,000,013 1,566,000,000   -1,836,997,321 1,391,000,000   3,639,996,816                      
      cash, cash equivalents, and restricted cash at beginning of period
    7,633,000,000  7,620,000,000  4,941,000,000             4,015,300,000         
      cash, cash equivalents, and restricted cash at end of period
    668,000,000 1,272,000,000 6,907,000,000  1,566,000,000 427,000,000 5,300,000,000  1,391,000,000 1,209,000,000 4,178,000,000  506,000,000 -590,000,000 4,569,000,000  358,000,000 217,000,000 7,064,000,000  -703,000,000 5,293,000,000 3,710,000,000 -137,400,000 3,723,100,000         
      components of cash, cash equivalents, and restricted cash
                                     
      cash and cash equivalents
    589,000,000 1,390,000,000 6,601,000,000  1,451,000,000 416,000,000 5,137,000,000  1,309,000,000 1,291,000,000 3,976,000,000  481,000,000                     
      cash, cash equivalents, and restricted cash
      116,000,000                               
      restricted cash
    79,000,000 -2,000,000 190,000,000  7,000,000 11,000,000 163,000,000  82,000,000 -82,000,000 202,000,000                       
      total cash, cash equivalents, and restricted cash
    668,000,000 1,272,000,000 6,907,000,000  1,566,000,000 427,000,000 5,300,000,000  1,391,000,000 1,209,000,000 4,178,000,000  506,000,000                     
      provision (credit) for deferred income taxes
          27,000,000   -321,000,000 -56,000,000             -226,500,000 -55,700,000 36,500,000   22,900,000     
      net proceeds in short-term borrowings
                                     
      benefit from deferred income taxes
      208,000,000                         479,700,000   6,000,000 -147,100,000 240,400,000 
      net decrease in cash, cash equivalents, and restricted cash
      -726,000,000    -2,320,000,000    -763,000,000             -137,400,000 -292,200,000         
      provision (credit) for credit losses
        91,000,000 100,000,000 31,000,000  25,000,000 41,000,000 -130,000,000                       
      net proceeds
          -2,951,000,000                           
      other non-cash adjustments
                                     
      gain on remeasurement of previously held equity investment
                                     
      collateral on derivatives - net
            -127,000,000 22,000,000 345,000,000                       
      increase in total short-term borrowings
            1,048,000,000 3,295,000,000 697,000,000             1,094,100,000 476,300,000 984,300,000   1,465,800,000   1,113,200,000 -1,074,900,000 
      proceeds from long-term borrowings
            5,104,000,000 2,363,000,000 2,505,000,000             2,021,100,000 2,211,100,000 1,661,400,000 1,815,600,000 2,262,100,000 1,702,900,000 1,365,800,000 1,295,800,000 1,444,600,000 1,832,000,000 
      payments of long-term borrowings
            -2,295,000,000 -1,642,000,000 -1,925,000,000             -1,485,500,000 -1,941,300,000 -1,483,100,000 -1,017,500,000 -1,871,200,000 -1,463,400,000 -1,693,300,000 -1,048,900,000 -1,505,300,000 -1,181,300,000 
      proceeds from sales of businesses and unconsolidated affiliates, net of cash sold
                             78,000,000 5,300,000 49,700,000 113,900,000   
      proceeds from issuance of common stock
             9,000,000 21,000,000             43,600,000 51,100,000 10,100,000 55,600,000 143,000,000 105,000,000 120,300,000 263,300,000 8,400,000 2,700,000 
      trade, notes, and financing receivables related to sales
              -1,015,000,000             -2,224,000,000 -507,300,000         
      impairment charges
                                   37,100,000 12,600,000 
      undistributed earnings of unconsolidated affiliates
                           -1,300,000 -7,300,000 -5,300,000 2,100,000 -6,600,000 -6,200,000 -2,100,000 -1,000,000 5,900,000 -600,000 
      decrease in total short-term borrowings
                               -535,500,000   -1,064,900,000   
      loss on sale of businesses and unconsolidated affiliates
                                     
      decrease (increase) in trade and wholesale receivables
                                     
      change in intercompany receivables/payables
                                     
      cash, cash equivalents, and restricted cash at beginning of year
                                     
      cash, cash equivalents, and restricted cash at end of year
                                     
      (gain) loss on sale of businesses and unconsolidated affiliates
                                     
      increase in investment in financial services
                                     
      capital investment from equipment operations
                                     
      (gain) loss on sales of businesses and unconsolidated affiliates
                                     
      gain on sales of businesses
                                     
      proceeds from sales of businesses, net of cash sold
                                     
      gain on sale of affiliates and investments
                             -11,900,000        
      trade, notes and financing receivables related to sales
                             -270,900,000 -2,059,200,000 -34,900,000 -101,600,000 -1,051,400,000 61,900,000 -1,356,400,000 44,900,000 
      effect of exchange rate changes on cash and cash equivalents
                             -73,800,000 -52,400,000 198,300,000 125,000,000 31,800,000 -39,300,000 85,900,000 -33,400,000 
      net increase in cash and cash equivalents
                             -278,100,000   2,011,600,000   673,300,000 -702,300,000 
      cash and cash equivalents at beginning of period
                             9,334,900,000 4,335,800,000 4,162,200,000 
      cash and cash equivalents at end of period
                             -278,100,000 286,300,000 3,915,100,000 2,011,600,000 635,800,000 3,890,000,000 673,300,000 3,459,900,000 
      net decrease in cash and cash equivalents
                               -5,419,800,000   -445,800,000   
      gain on sale of unconsolidated affiliates and investments
                                -93,700,000     
      excess tax benefits from share-based compensation
                                 5,600,000 5,700,000 1,700,000 1,000,000 
      insurance receivables
                                     
      proceeds from sale of business, net of cash sold
                                     
      cash and cash equivalents at beginning of year
                                     
      cash and cash equivalents at end of year
                                     
      credit for credit losses
                                     
      benefit from doubtful receivables
                                     
      provision (credit) for doubtful receivables
                                     
      government grants related to property and equipment
                                     
      cost of receivables
                                     
      increase in short-term borrowings
                                     
      proceeds from sales of financing receivables
                                     
      goodwill impairment charge
                                     
      cost of financing receivables acquired
                                     
      gain on the sale of a business
                                     
      retirement benefit accruals/prepaid pension costs
                                     
      collections of financing receivables
                                     
      trade, notes and financing receivables related to sales of equipment
                                     
      see notes to interim financial statements.
                                     
      undistributed earnings of unconsolidated subsidiaries and affiliates
                                     
      receivables
                                     
      cost of operating leases acquired
                                     
      principal payments on long-term borrowings
                                     
      effect of exchange rate changes on cash
                                     
      proceeds from sales of businesses
                                     
      increase in receivables from unconsolidated affiliates
                                     
      increase in receivables with unconsolidated affiliates
                                     
      other*
                                     
      decrease (increase) in receivables from unconsolidated affiliates
                                     
      benefit from doubtful receivable
                                     
      proceeds from sale of a business
                                     
      purchases of properly and equipment
                                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.